Ovarian Neoplasms
Conditions
Brief summary
The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
Detailed description
The researchers retrospectively collected data on Korean patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. And the researchers prospectively will collect data on all Korean patients with BOTs at institutions where placed in the Republic of Korea since March, 2015. If patients agree to participate in this KOBOT registry, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.
Interventions
None listed
Sponsors
Kangbuk Samsung Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. * All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015
Exclusion criteria
* Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-free survival | up to 100 months |
Countries
South Korea
Contacts
Primary ContactTaejong Song, MD,PhD
Outcome results
None listed